Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes - Test2 - elhamkhani - TriplyDB

Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes

Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes

http://www.wikidata.org/entity/Q27004274

about

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus Renal effects of dapagliflozin in patients with type 2 diabetes Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR Incretin-Based Therapy for Prevention of Diabetic Vascular Complications New Insights for Oxidative Stress and Diabetes Mellitus Improvements in the Management of Diabetic Nephropathy NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice Teneligliptin in Management of Diabetic Kidney Disease: A Review of Place in Therapy.Diabetic Kidney Disease: A Syndrome Rather Than a Single Disease.Management of diabetes mellitus in patients with chronic kidney disease Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases.Nephropathy in youth and young adults with type 2 diabetes Diabetic nephropathy for the primary care provider: new understandings on early detection and treatment An Evidence-Based Medicine Approach to Antihyperglycemic Therapy in Diabetes Mellitus to Overcome Overtreatment.Extreme Levels of HbA1c Increase Incident ESRD Risk in Chinese Patients with Type 2 Diabetes: Competing Risk Analysis in National Cohort of Taiwan Diabetes Study Association of hypoglycemia with incident chronic kidney disease in patients with type 2 diabetes: a nationwide population-based study Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease Prevalence of unrecognized diabetes, prediabetes and metabolic syndrome in patients undergoing elective percutaneous coronary intervention Awaking Blood Pressure Surge and Progression to Microalbuminuria in Type 2 Normotensive Diabetic Patients.Comprehensive approach to diabetic nephropathy.Novel directions for diabetes mellitus drug discovery Glycated Hemoglobin and Outcomes in Patients with Advanced Diabetic Chronic Kidney Disease Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis.Significance of microalbuminuria in relation to subclinical coronary atherosclerosis in asymptomatic nonhypertensive, nondiabetic subjects.Fiber in Diet Is Associated with Improvement of Glycated Hemoglobin and Lipid Profile in Mexican Patients with Type 2 Diabetes Prevalence and Management of Diabetic Nephropathy in Western Countries.Nonadherence of Oral Antihyperglycemic Medication Will Increase Risk of End-Stage Renal Disease.Introduction to personalized medicine in diabetes mellitus.Silent diabetic nephropathy.Targets for body fat, blood pressure, lipids, and glucose-lowering interventions in healthy older people.Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study.Reducing cardiovascular disease risk in type 2 diabetes: is the focus on glycaemia warranted?The gut-renal axis: do incretin-based agents confer renoprotection in diabetes?Targeting cellular drivers and counter-regulators of hyperglycaemia- and transforming growth factor-β1-associated profibrotic responses in diabetic kidney disease.Novel effective drugs for diabetic kidney disease? or not?Programming apoptosis and autophagy with novel approaches for diabetes mellitus.Nitric oxide and the cardiovascular system.Sodium-Glucose Cotransporter 2 Inhibitors with Renoprotective Effects.Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression.

P2860

Q24186667-905D89C2-5456-457E-BBE7-02AF24E829EB Q24202505-15256C08-37B4-45DC-B07D-FD7E55A22159 Q24564811-0A46F891-6D10-4CB5-8880-1B74E665DB71 Q26749047-6CD37764-E33F-4309-BBCA-0FDC538D1B07 Q26765470-A4008A6F-8827-4B05-822B-ED61701AC0ED Q28080679-44F71E50-096E-4E9A-BD92-69BABA7F1558 Q28080717-6342E224-3E11-48AA-BAF1-E9476D72AAAD Q28661524-2BB39F2C-3FBE-4C34-BA45-7EB415631128 Q30399639-C9F9FE36-1CEE-4BEC-B48F-D11252AE0F79 Q33583012-CC953F54-1EB4-473D-8B17-16D213DA9C7A Q33792375-14F3A3FA-F975-4B7F-855A-759AE6948B5B Q33799767-4E301239-97FF-4A07-A8D4-9ED7861B0180 Q33903763-8DFF3A82-D4D2-4F1E-924D-E43C161B8169 Q34228586-26EE0F5C-1F1B-4E16-A664-A452E29FFFB1 Q34548875-168AFFD5-D41A-4472-B9FB-DE27E85CFA2C Q35670828-D4986338-0AC7-448C-A6F8-A5C2A188E20B Q36152043-86C74F50-BF1C-408A-B4B2-60EABA1443FA Q36314954-7B5B6679-7762-41B7-B57C-029936F668E0 Q36412515-89E489DF-F411-4B7A-AC3E-623AFBB8D65B Q36448380-D5668A2F-B361-43E4-9CEA-4176A15DED78 Q36466019-72505D45-8A3A-457C-8CDF-824E0C66E9AF Q36487424-A10D3B93-C52F-4A1A-822C-3A8510840D0B Q36512204-221E7287-A3CC-4CD2-A114-1CB76849A3F1 Q36589609-76DE8087-C5D3-46C8-8EF1-68D86557890B Q36675559-42A19ADA-066D-4FAC-9DD2-E7C5CF9DC299 Q36828264-AE32CEF1-2429-4B7B-A18D-10515078EB5D Q37069905-177D0D5B-2D92-4D78-9D9E-B9EC0444BAE3 Q37328563-17651B6F-5D9A-45EF-A1B8-16EBF34D441F Q37523745-953355BD-5203-460D-B1CC-7B8FEC53EB11 Q37576112-805E9CE2-FE40-4F9C-8827-9B8F45A3DB5C Q37577151-FBA5EC84-774B-433A-BD79-1ED0E98D227E Q37631209-B4105091-2C8A-42D9-9BF5-5C476B6123A9 Q38047379-7A1515F8-E610-4BA5-AB12-33C2B2EEB09A Q38174491-8EA302DD-AC4C-4DFC-9702-35FC6E972F8A Q38236212-FDA69954-EF14-4EDB-B6BB-E0D7F40469C0 Q38265818-EB10E78F-F32C-4AD4-8B8E-5E25772BE613 Q38367977-7B82A29B-FD52-49EF-865F-6D8D8ED02F9C Q38423876-932C9901-A2C6-44C9-83C8-E330664771A0 Q38635763-234F4F82-FBAB-441C-AFC5-E450BF25B313 Q38661556-E996106D-686D-4334-BCD4-D332AB21E06B

P2860

Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes

http://www.wikidata.org/entity/Q27004274

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Role of intensive glucose cont ...... ose control in type 2 diabetes

@ast

Role of intensive glucose cont ...... ose control in type 2 diabetes

@en

Role of intensive glucose cont ...... ose control in type 2 diabetes

@nl

type

label

Role of intensive glucose cont ...... ose control in type 2 diabetes

@ast

Role of intensive glucose cont ...... ose control in type 2 diabetes

@en

Role of intensive glucose cont ...... ose control in type 2 diabetes

@nl

prefLabel

Role of intensive glucose cont ...... ose control in type 2 diabetes

@ast

Role of intensive glucose cont ...... ose control in type 2 diabetes

@en

Role of intensive glucose cont ...... ose control in type 2 diabetes

@nl

P1433

Q27004274-308DFEB1-5020-491B-AD47-8D0B11217AA6

P1476

Q27004274-44EE14F5-A2CA-4865-AA86-BF2C6D030670

P2093

Q27004274-1DBAD770-8393-4CAE-A5DF-15C731620AEF

Q27004274-5D5D9CF2-ADB4-489E-B310-AC0BCD4A1DE0

Q27004274-9149B24D-EB24-452E-ADBC-C5BAE8C4DE5C

P2860

Q27004274-1574C3B9-D472-4170-B74C-B59D22731399

Q27004274-20C1A468-B76A-4A91-AFA4-F7FC7EBF9F44

Q27004274-53378E1E-EAD2-4E35-A120-872E1531B5AF

Q27004274-8E239828-A226-40F7-A769-68C42CBCB3AD

Q27004274-94021836-8451-485F-826F-BF7144D4C07D

Q27004274-96BE597F-F113-4F85-8701-9CFA6C31207D

Q27004274-A12866E9-773F-4D2C-B0F1-A1872C226AC0

Q27004274-A2FF8C73-F940-46E7-BB48-CF8BA0308199

Q27004274-A315F8AD-6891-4A10-AA0E-68125663A706

Q27004274-B176E1A4-B151-44A0-A414-56082E853252

P304

Q27004274-DE7C05CC-663F-4C24-B73B-B8C07325319F

P31

Q27004274-7448FF35-86EF-439D-A908-8705C3F3F76A

Q27004274-AFCC017D-79AD-442C-92FC-D68116840289

Q27004274-FA720CD3-D920-4E23-8FA2-84EF62F14150

P3181

Q27004274-26A0A24A-A7B0-425B-B377-03643381F1E6

P356

Q27004274-AAA1D14D-5D28-4688-A19D-0723E967A12E

P407

Q27004274-3DF5305E-63BA-4FDC-AFE3-18AC2997A14E

P433

Q27004274-25F0BFFA-3C0B-44D6-AFB5-ACA2DFCF5D28

P478

Q27004274-95AD8371-856D-4046-825D-849AEF6D3382

P50

Q27004274-32393E9D-938E-4807-B1DF-D13A221E57BB

Q27004274-78447CA0-7ED7-4B0F-8B12-70E3E6EA9690

P577

Q27004274-632084B7-7C63-4AA4-A3DA-C9273C2900CB

P698

Q27004274-BAFD4F15-1007-4091-9C26-644709FF2D2F

P921

Q27004274-6C665D55-31B8-4A06-A967-FF20658F6E54

Q27004274-77CC4455-0AD9-4BA8-B9FC-3E3D263E1C2F

Q27004274-7f975500-a219-46a2-abf3-f4ae106b4eea

Q27004274-C53DFBB1-49F9-4326-8150-07C791AE6305

P932

Q27004274-0887FD06-110D-4E75-B41F-45D2A309B9A2

P3181

P356

ARCHINTERNMED.2011.2230

P1433

JAMA Internal Medicine

P1476

Role of intensive glucose cont ...... ose control in type 2 diabetes

@en

P2093

Chirag R Parikh

http://www.w3.org/2001/XMLSchema#string

Faramarz Ismail-Beigi

http://www.w3.org/2001/XMLSchema#string

Nowreen Haq

http://www.w3.org/2001/XMLSchema#string

P2860

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Measuring inconsistency in meta-analyses

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Effects of intensive glucose lowering in type 2 diabetes

Glucose control and vascular complications in veterans with type 2 diabetes

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

P304

761-769

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P3181

2395752

http://www.w3.org/2001/XMLSchema#string

P356

10.1001/ARCHINTERNMED.2011.2230

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

172

http://www.w3.org/2001/XMLSchema#string

P50

Harlan M. Krumholz

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22636820

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3688081

http://www.w3.org/2001/XMLSchema#string